Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Radjin Steingrover"'
Autor:
Marlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E van der Ende, Robin Soetekouw, Frank de Wolf, Joep M A Lange, Hanneke Schuitemaker, Jan M Prins, Primo-SHM Study Group
Publikováno v:
PLoS Medicine, Vol 9, Iss 3, p e1001196 (2012)
BackgroundThe objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI).Methods and findingsAdult patients with laboratory evidence of PHI were recruited in 13 HIV trea
Externí odkaz:
https://doaj.org/article/8e6a2f676214485ba7715210584060c3
Autor:
Maria Henry, Sanne van Kampen, Chérina Fleming, Colin King, Eva Lista-de Weever, Richard Panneflek, Radjin Steingrover
ObjectivesControl of the pandemic has required countries to look for other forms of tests besides the gold standard real-time polymerase chain reaction (RT-PCR). Rapid antigen tests (RAT), though less sensitive than RT-PCR, offer the possibility of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0122ab75df957f71f2aa2bbc07d0841
https://doi.org/10.1101/2021.09.23.21260526
https://doi.org/10.1101/2021.09.23.21260526
Autor:
Nening M. Nanlohy, Ingrid M. M. Schellens, Marlous L. Grijsen, Debbie van Baarle, Neeltje A. Kootstra, José A. M. Borghans, Hilde B. Spits, Jan M. Prins, Radjin Steingrover
Publikováno v:
Viral immunology, 28(3), 134-144. Mary Ann Liebert Inc.
The Primo-SHM trial, a multicenter randomized trial comparing no treatment with 24 or 60 weeks of combination antiretroviral therapy (cART) during primary human immunodeficiency virus (HIV) infection (PHI), recently demonstrated that temporary early
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Jan M. Prins, F. De Wolf, M.E.E. van Kasteren, GJ Kootstra, Marlous L. Grijsen, Pythia T. Nieuwkerk, Radjin Steingrover, Gaia T Koster, Mga van Vonderen
Publikováno v:
HIV Medicine. 13:630-635
Objectives The aim of the study was to compare health-related quality of life (HRQL) over 96 weeks in patients receiving no treatment or 24 or 60 weeks of combination antiretroviral therapy (cART) during primary HIV-1 infection (PHI). Methods A multi
Publikováno v:
Open Forum Infectious Diseases. 4:S302-S303
Background Zika virus (ZIKV) was introduced in the Caribbean island of Curacao in January 2016. A commercially available ZIKV IgM and IgG ELISA was evaluated on patients that were PCR-positive for ZIKV. Methods ZIKV infection was established by PCR i
Autor:
Jan M. Prins, Frank de Wolf, Luuk Gras, Radjin Steingrover, Agnes M. Harskamp, Irma Maurer, Marga M. Mangas Ruiz, Angélique B. van 't Wout, Brigitte Boeser-Nunnink, Ard van Sighem, Daniëlle van Manen, Hanneke Schuitemaker
Publikováno v:
AIDS (London, England), 25(18), 2217-2226. Lippincott Williams and Wilkins
Objective: Heterozygosity for a 32 base pair deletion in the CCR5 gene (CCR5wt/Δ32) and the minor alleles of a single-nucleotide polymorphism in the HCP5 gene (rs2395029) and in the HLA-C gene region (−35HLA-C; rs9264942) has been associated with
Autor:
Suzanne Jurriaans, Jan M. Prins, Karolina Kozaczynska, Radjin Steingrover, Fokla Zorgdrager, Marion Cornelissen, Antoinette C. van der Kuyl
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 47(1), 69-73. Lippincott Williams and Wilkins
Objective: To investigate the association between an unexpected increase in the blood plasma HIV-1 viral load in chronically untreated HIV-infected patients and the occurrence of an HIV superinfection, we analyzed the HIV-1 quasispecies in plasma sam
Autor:
Kees Brinkman, Frank Miedema, Evian Fernandez Garcia, Hanneke Schuitemaker, Radjin Steingrover, Jan M. Prins, Katalyn Pogány, Suzanne Jurriaans, Joep M. A. Lange
Publikováno v:
AIDS (London, England), 22(13), 1583-1588. Lippincott Williams and Wilkins
AIDS, 22(13), 1583. Lippincott Williams and Wilkins
AIDS, 22(13), 1583. Lippincott Williams and Wilkins
Objective: An important pending question is whether temporary highly active antiretroviral therapy during primary HIV infection can influence viral rebound dynamics and the subsequently established viral setpoint, through preservation and enhancement
Autor:
Sven A. Danner, Frank de Wolf, Ferdinand W. N. M. Wit, Marjan Weeda, Johan Schuijtemaker, Suzanne Jurriaans, Joep M. A. Lange, Peter Reiss, Remko van Leeuwen, Gerrit Jan Weverling, Radjin Steingrover, David Fortuin, Xander Eyssen, Klaas Nauta
Publikováno v:
The Journal of Infectious Diseases, 179, 790-798. Oxford University Press
Wit, F W N M, Van Leeuwen, R, Weverling, G J, Jurriaans, S, Nauta, K, Steingrover, R, Schuijtemaker, J, Eyssen, X, Fortuin, D, Weeda, M, De Wolf, F, Reiss, P, Danner, S A & Lange, J M A 1999, ' Outcome and predictors of failure of highly active antiretroviral therapy : One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons ', Journal of Infectious Diseases, vol. 179, no. 4, pp. 790-798 . https://doi.org/10.1086/314675
Journal of infectious diseases, 179(4), 790-798. Oxford University Press
Journal of Infectious Diseases, 179(4), 790-798. Oxford University Press
Wit, F W N M, Van Leeuwen, R, Weverling, G J, Jurriaans, S, Nauta, K, Steingrover, R, Schuijtemaker, J, Eyssen, X, Fortuin, D, Weeda, M, De Wolf, F, Reiss, P, Danner, S A & Lange, J M A 1999, ' Outcome and predictors of failure of highly active antiretroviral therapy : One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons ', Journal of Infectious Diseases, vol. 179, no. 4, pp. 790-798 . https://doi.org/10.1086/314675
Journal of infectious diseases, 179(4), 790-798. Oxford University Press
Journal of Infectious Diseases, 179(4), 790-798. Oxford University Press
The outcome and predictors of virologic treatment failure of highly active antiretroviral therapy (HAART) were determined for 271 human immunodeficiency virus (HIV)-infected protease inhibitor-naive persons. During a follow-up of 48 weeks after the i